NCT05235828 is a NA clinical trial of Sudarshan Kriya Yoga (SKY) in PTSD, sponsored by Mount Sinai Hospital, Canada.

Who is sponsoring NCT05235828?

NCT05235828 is sponsored by Mount Sinai Hospital, Canada.

What drugs are being tested in NCT05235828?

Interventions in NCT05235828: Sudarshan Kriya Yoga (SKY).

What condition does NCT05235828 study?

NCT05235828 studies PTSD, Depressive Symptoms, Anxiety, Pain, Quality of Life, Post Traumatic Stress Disorder.

Is NCT05235828 still recruiting?

NCT05235828 is currently status unknown. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT05235828

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Studying the Effectiveness and Implementation of Sudarshan Kriya Yoga for Canadian Veterans With PTSD

Status unknown NA Last updated 16 March 2023

What this trial tests

NA trial testing Sudarshan Kriya Yoga (SKY) in PTSD in 200 participants. Status unknown.

Timeline

25 April 2022

Primary endpoint
31 January 2024

1 July 2024

Quick facts

Lead sponsor	Mount Sinai Hospital, Canada
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	25 April 2022
Primary completion	31 January 2024
Estimated completion	1 July 2024
Sites	1 location across Canada

Drugs / interventions tested

Sudarshan Kriya Yoga (SKY)

Conditions studied

PTSD — all drugs for PTSD →
Depressive Symptoms — all drugs for Depressive Symptoms →
Anxiety — all drugs for Anxiety →
Pain — all drugs for Pain →

Sponsor

Mount Sinai Hospital, Canada

Who can join

18 and older, any sex, with PTSD or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We plan to study the reach, effectiveness, adoption, implementation, and maintenance of the virtually-delivered Sudarshan Kriya Yoga (v-SKY) intervention. We will study effectiveness by comparing the effects of v-SKY to a waitlist control in a randomized controlled trial (RCT) with Canadian military and RCMP veterans with PTSD. Effects of the intervention on PTSD symptom severity, depression, pain, anxiety, and quality of life will be evaluated. We will evaluate the reach, adoption, implementation, and maintenance of the v-SKY intervention amongst veterans, SKY instructors, health professionals, and administrators by interviewing RCT participants, instructors, health professionals, and administrators that work with veterans. Evaluating implementation of a virtual intervention is relevant in both pandemic and post-pandemic contexts where virtual interventions may continue to be more available and possibly preferred by patients and clients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Virtually-delivered Sudarshan Kriya Yoga (SKY) for Canadian veterans with PTSD: A study protocol for a nation-wide effectiveness and implementation evaluation.
Ryk J, Simpson R, Hosseiny F, Notarianni M, et al · · 2022 · cited 3× · PMID 36288364 · DOI 10.1371/journal.pone.0275774

Verify or expand the search:

Other trials of Sudarshan Kriya Yoga (SKY)

Trials testing the same drug.

NCT04368676 — Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic · EARLY_PHASE1 · terminated

Other recruiting trials for PTSD

Currently open trials in the same condition.

NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting

Other Mount Sinai Hospital, Canada trials

Trials by the same sponsor.

NCT07272460 — Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial · NA · recruiting
NCT07046572 — Methoxyflurane for IUD Insertion and Endometrial Biopsy · NA · recruiting
NCT06504277 — Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain · NA · recruiting
NCT06546254 — 1% Lidocaine Paracervical Block for Endometrial Biopsy · NA · completed
NCT06733701 — The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05235828 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mount Sinai Hospital, Canada
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05235828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing